Current Surgical Management of Ovarian Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Current Surgical Management of Ovarian Cancer

Surgical management of ovarian cancer requires excellent judgment and mastery of a wide array of procedures. Involvement of a gynecologic oncologist improves outcomes. Staging of apparent stage I disease is important….

read more

Surgical Management of Cervical Carcinoma

Mar 1, 2017 by in HEMATOLOGY Comments Off on Surgical Management of Cervical Carcinoma

Cervical cancer is the second most common cancer in women worldwide. In developed countries screening programs have decreased the incidence of this disease and improved the detection of early-stage disease…

read more

Current Management of Gestational Trophoblastic Neoplasia

Mar 1, 2017 by in HEMATOLOGY Comments Off on Current Management of Gestational Trophoblastic Neoplasia

Gestational trophoblastic neoplasms are malignant lesions that arise from placental villous and extravillous trophoblast. Four clinicopathologic conditions make up this entity: invasive mole (IM), choriocarcinoma (CCA), placental-site trophoblastic tumor (PSTT),…

read more

Current Surgical Management of Endometrial Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Current Surgical Management of Endometrial Cancer

Despite being the most common gynecologic cancer in developed countries, there are many unanswered questions regarding optimal surgical management of endometrial cancer, including who should undergo surgical staging. There is…

read more

Current Management of Vulvar Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Current Management of Vulvar Cancer

Vulvar cancer is surgically staged and is categorized by the pathologic evaluation of the vulvar tumor and the inguinofemoral lymph nodes. All tumors more invasive than 1 mm and larger…

read more

Management of Cervical Precancers: A Global Perspective

Mar 1, 2017 by in HEMATOLOGY Comments Off on Management of Cervical Precancers: A Global Perspective

The incidence and mortality of cervical cancer have decreased dramatically over the past 70 years in well-developed countries through successful screening programs using cytologic examination, followed by evaluation and treatment…

read more

Genetic Risk and Gynecologic Cancers

Mar 1, 2017 by in HEMATOLOGY Comments Off on Genetic Risk and Gynecologic Cancers

Hereditary cancer syndromes are responsible for 5% of endometrial cancers and 10% of ovarian cancers. Hereditary breast and ovarian cancer syndrome and Lynch syndrome account for most of these inherited…

read more
Get Clinical Tree app for offline access